Recent Advances in Neuroblastoma
Top Cited Papers
- 10 June 2010
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 362 (23) , 2202-2211
- https://doi.org/10.1056/nejmra0804577
Abstract
Neuroblastoma, an embryonal cancer of the autonomic nervous system, is the most common cancer diagnosed during the first year of life. Although neuroblastoma accounts for disproportionately high morbidity and mortality among childhood cancers, it has one of the highest rates of spontaneous and complete regression. The author discusses recent advances in our understanding of neuroblastoma.Keywords
This publication has 71 references indexed in Scilit:
- Initial testing of the aurora kinase a inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP)Pediatric Blood & Cancer, 2010
- Copy number variation at 1q21.1 associated with neuroblastomaNature, 2009
- Common variations in BARD1 influence susceptibility to high-risk neuroblastomaNature Genetics, 2009
- Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task ForceBritish Journal of Cancer, 2009
- Somatic and germline activating mutations of the ALK kinase receptor in neuroblastomaNature, 2008
- Activating mutations in ALK provide a therapeutic target in neuroblastomaNature, 2008
- Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastomaNuclear Medicine and Biology, 2008
- Identification of ALK as a major familial neuroblastoma predisposition geneNature, 2008
- Chromosome 6p22 Locus Associated with Clinically Aggressive NeuroblastomaNew England Journal of Medicine, 2008
- High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trialThe Lancet Oncology, 2008